The once far-fetched idea of engineering the body’s own immune cells to fight diseases is now an exciting reality. From the well-known chimeric antigen receptor (CAR) T cell therapy to the promising developments in allogenic and CAR natural killer (NK) cells, scientists continue to expand the cell therapy portfolio, creating new possibilities for treating cancer and various other diseases.
Download this compendium from Drug Discovery News and its life sciences supporter, CellCarta, to explore the science behind different CAR-based cell therapy approaches and the latest strategies driving the development of effective cell therapies.
Here’s a sneak peek at what’s inside
- Explainer: how does CAR T cell therapy work?
- eBook: unconventional approaches to cell therapy
- Poster: exploring CAR NK cells
- Guide: evaluating trends in cell therapy clinical testing
